These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 17584689)

  • 21. [Microvolt level T wave alternans: a new marker for noninvasive risk stratification].
    Klingenheben T; Credner S; Li YG; Bender B; Hohnloser SH
    Z Kardiol; 2000; 89 Suppl 3():57-61. PubMed ID: 10810786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
    Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
    J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction.
    Cantillon DJ; Stein KM; Markowitz SM; Mittal S; Shah BK; Morin DP; Zacks ES; Janik M; Ageno S; Mauer AC; Lerman BB; Iwai S
    J Am Coll Cardiol; 2007 Jul; 50(2):166-73. PubMed ID: 17616302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal.
    Chan PS; Bartone C; Booth T; Kereiakes D; Chow T
    Am Heart J; 2007 Apr; 153(4):523-9. PubMed ID: 17383288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microvolt T-wave alternans testing for ventricular arrhythmia risk stratification.
    Chow T; Joshi D
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):833-42. PubMed ID: 18570621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognostic value of microvolt level T-wave alternans in patients at high risk of sudden cardiac death].
    Yang P; Guo T; Tang YM; Zhao L; Li SM; Liu ZM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun; 36(6):517-22. PubMed ID: 19100065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure.
    Jackson CE; Myles RC; Tsorlalis IK; Dalzell JR; Spooner RJ; Rodgers JR; Bezlyak V; Greenlaw N; Ford I; Cobbe SM; Petrie MC; McMurray JJ
    Eur J Heart Fail; 2012 Apr; 14(4):377-86. PubMed ID: 22334727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Arrhythmia risk stratification in patients with heart failure: prognostic evaluation of arrhythmia risk].
    Lombardi F
    Ital Heart J Suppl; 2001 Dec; 2(12):1284-90. PubMed ID: 11838349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microvolt T wave alternans (MTWA)--a new non-invasive predictor of sudden cardiac death.
    Predescu D; Mitruţ P; Giucă A
    Rom J Intern Med; 2004; 42(3):647-56. PubMed ID: 16366137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study.
    Ikeda T; Yoshino H; Sugi K; Tanno K; Shimizu H; Watanabe J; Kasamaki Y; Yoshida A; Kato T
    J Am Coll Cardiol; 2006 Dec; 48(11):2268-74. PubMed ID: 17161258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do Beta-blockers impact microvolt T-wave alternans testing in patients at risk for ventricular arrhythmias? A meta-analysis.
    Chan PS; Gold MR; Nallamothu BK
    J Cardiovasc Electrophysiol; 2010 Sep; 21(9):1009-14. PubMed ID: 20384655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter by De Ferrari and Verrier regarding article, "Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy".
    De Ferrari GM; Verrier RL
    Circulation; 2009 Jul; 120(3):e20; author reply e22. PubMed ID: 19620521
    [No Abstract]   [Full Text] [Related]  

  • 33. Sudden death prophylaxis in heart failure.
    Rosanio S; Schwarz ER; Vitarelli A; Zarraga IG; Kunapuli S; Ware DL; Birnbaum Y; Tuero E; Uretsky BF
    Int J Cardiol; 2007 Jul; 119(3):291-6. PubMed ID: 17208319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to do exercise-induced T-wave alternans testing using the spectral method.
    Klingenheben T; Ptaszyński P
    Cardiol J; 2008; 15(3):288-92. PubMed ID: 18651425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microvolt T-wave alternans during atrial and ventricular pacing.
    Shalaby AA; Voigt A; El-Saed A; Mains M; Shusterman V
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S178-82. PubMed ID: 17302700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectral microvolt T-wave alternans testing has no prognostic value in patients recently hospitalized with decompensated heart failure.
    Jackson CE; Myles RC; Tsorlalis IK; Dalzell JR; Rocchiccioli JP; Rodgers JR; Spooner RJ; Greenlaw N; Ford I; Gardner RS; Cobbe SM; Petrie MC; McMurray JJ
    Eur J Heart Fail; 2013 Nov; 15(11):1253-61. PubMed ID: 23703105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immediate ventricular tachycardia after abnormal microvolt T-wave alternans.
    Sedkowska A; Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Kalarus Z
    Cardiol J; 2009; 16(4):365-7. PubMed ID: 19653182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy.
    Gold MR; Ip JH; Costantini O; Poole JE; McNulty S; Mark DB; Lee KL; Bardy GH
    Circulation; 2008 Nov; 118(20):2022-8. PubMed ID: 18955671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of microvolt T-wave alternans to predict outcomes in patients with ischemic cardiomyopathy beyond one year.
    Chan PS; Kereiakes DJ; Bartone C; Chow T
    Am J Cardiol; 2008 Aug; 102(3):280-4. PubMed ID: 18638586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.